10-Q

Company

Kiniksa Pharmaceuticals International, plc

Filed

October 28, 2025

Period of Report

September 30, 2025

Accession Number

0001104659-25-103180

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →